Incremental conversion of outer-membrane permeabilizers into potent antibiotics for gram-negative bacteria

Journal of the American Chemical Society

Volumn 121, Issue 5, 1999, Pages 931-940

  Li, Chunhong ^a   Budge, Loren P ^a   Driscoll, Collin D ^a   Willardson, Barry M ^a   Allman, Glenn W ^a   Savage, Paul B ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROSTREPTOMYCIN; ERYTHROMYCIN; POLYMYXIN B; POLYMYXIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; DRUG PENETRATION; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; NONHUMAN; OUTER MEMBRANE;

EID: 0033540629     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja982938m     Document Type: Article

References (45)

1. Galanos, C.; Luderitz, O.; Rietshel, E. T.; Westphal, O.; Brade, H.; Brade, L.; Freudenberg, M.; Schade, U.; Imoto, M.; Yoshimura, H.; Kusumoto, S.; Shiba, T. Eur. J. Biochem. 1985, 148, 1.
2. Galanos, C.; Lüderitz, O.; Rietschel, E. T.; Westphal, O. Int. Rev. Biochem. 1977, 14, 239.
3. (a) Vaara, M. Microbiol. Rev. 1992, 56, 395.
4. (b) Nikaido, H.; Vaara, M. Microbiol. Rev. 1985, 49, 1.
5. (c) Hancock, R. E. W. Annu. Rev. Microbiol. 1984, 38, 237.
6. For examples see: (a) Beacham, I. R.; Kahana, R.; Levy, L.; Yagil, E. J. Bacteriol. 1973, 116, 957. (b) Brown, M. R. W.; Richards, R. M. E. Nature 1965, 207, 1391.
7. For examples see: (a) Beacham, I. R.; Kahana, R.; Levy, L.; Yagil, E. J. Bacteriol. 1973, 116, 957. (b) Brown, M. R. W.; Richards, R. M. E. Nature 1965, 207, 1391.
8. For examples see: (a) Hancock, R. E. W.; Raffle, V. J.; Nicas, T. I. Antimocrob. Agents Chemother. 1981, 19, 777. (b) Reynolds, B. L.; Pruul, H. Infect. Immun. 1971, 3, 365.
9. For examples see: (a) Hancock, R. E. W.; Raffle, V. J.; Nicas, T. I. Antimocrob. Agents Chemother. 1981, 19, 777. (b) Reynolds, B. L.; Pruul, H. Infect. Immun. 1971, 3, 365.
10. Weiss, J.; Elsbach, P.; Olson, K.; Odeberg, H. J. Biol. Chem. 1978, 253, 2664.
11. (a) Vaara, M.; Porro, M. Antimicrob. Agents Chemother. 1996, 40, 1801.
12. (b) Maloy, W. L.; Kari, U. P. Biopolymers 1995, 37, 105.
13. (c) Hancock, R. E. W.; Falla, T.; Brown, M. Adv. Microb. Physiol. 1995, 37, 135.
14. (a) Morris, C. M.; George, A.; Wilson, W. W.; Champlin, F. R. J. Antibiot. 1995, 48, 67.
15. (b) Ofek, I.; Cohen, S.; Rahmani, R.; Kabha, K.; Tamarkin, D.; Herzig, Y.; Rubenstein, E. Antimicrob. Agents Chemother. 1994, 38, 374.
16. (c) Vaara, M. Antimicrob. Agents Chemother. 1993, 37, 354.
17. (d) Kimura, Y.; Matsunaga, H.; Vaara, M. J. Antibiot. 1992, 45, 742.
18. (e) Viljanen, P.; Matsunaga, H.; Kimura, Y.; Vaara, M. J. Antibiot. 1991, 44, 517.
19. (f) Vaara, M. Drugs Exp. Clin. Res. 1991, 17, 437.
20. (g) Peterson, A. A.; Hancock, R. E. W.; McGroarty, E. J. J. Bacteriol. 1985, 164, 1256.
21. (h) Vaara, M.; Vaara, T. Antimicrob. Agents Chemother. 1983, 24, 107.
22. (i) Vaara, M.; Vaara, T. Antimicrob. Agents Chemother. 1983, 24, 114.
23. (j) Vaara, M.; Vaara, T. Nature. 1983. 303, 526.
24. (a) Taylor, A. H.; Heavner, G.; Nedelman, M.; Sherris, D.; Brunt, E.; Knight, D.; Ghrayeb, J. J. Biol. Chem. 1995, 270, 17934.
25. (b) Guzzano-Santoro, H.; Parent, J. B.; Grinna, L.; Horwitz, A.; Parsons, T.; Theofan, G.; Elsbach, P.; Weiss, J.; Conlon, P. J. Infect. Immun. 1992, 60, 4754.
26. (c) David, S. A.; Balasubramanian, K. A.; Mathan, V. I.; Balaram, P. Biochim. Biophys. Acta 1992, 1165, 147.
27. (d) Moore, R. A.; Bates, N. C.; Hancock, R. E. W. Antimicrob. Agents Chemother. 1986, 29, 496.
28. Cerny, G.; Teuber, M. Arch. Mikrobiol. 1971, 78, 166.
29. Li, C.; Peters, A. S.; Meredith, E. L.; Allman, G. W.; Savage, P. B. J. Am. Chem. Soc. 1998, 120, 2961.
30. Barton, D. H. R.; Wozniak, J.; Zard, S. Z. Tetrahedron 1989, 45, 3741.
31. Meystre, C.; Wettstein, A. Helv. Chim. Acta 1947, 30, 1256.
32. Conte, J. E., Jr. Manual of Antibiotics and Infectious Diseases; Williams & Wilkins: Philadelphia, 1995.
33. Many clinically useful antibiotics against Gram-negative bacteria have MIC values of ca. 1 μg/mL (see ref 14).
34. Obtained from Boehringer Mannheim as 95% pure PMBN and used as received.
35. Permeabilization is classified as a "sublethal action"; see ref 3a. DAPB (3), PMBN (4), PMBH (5), and 6-11 can cause increases in permeability at concentrations much lower than their corresponding MBC values.
36. Wiese, A.; Münsterman, M.; Gutsmann, T.; Linder, B.; Kawahara, K.; Zähringer, U.; Seydel, U. J. Membr. Biol. 1998, 162, 127.
37. Schöder, G.; Brandenburg, K.; Seydel, U. Biochemistry 1992, 31, 631.
38. Elion, G. B.; Singer, S.; Hitchings, G. H. J. Biol. Chem. 1954, 208, 477.
39. P. aeruginosa strains are typically more antibiotic resistant than strains of E. coli; see ref 14.
40. Moore, K. S.; Wehrli, S.; Roder, H.; Rogers, M.; Forrest, J. N., Jr.; McCrimmon, D.; Zasloff, M. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1354.
41. (a) Kikuchi, K.; Bernard, E. M.; Sadownik, A.; Regen, S. L.; Armstrong, D. Antimicrob. Agents Chemother. 1997, 41, 1433.
42. (b) Deng, G.; Dewa, T.; Regen, S. L. J. Am. Chem. Soc. 1996, 118, 8975.
43. (a) Willardson, B. M.; Wilkins, J. F.; Rand, T. A.; Schupp, J. M.; Hill, K. K.; Keim, P.; Jackson, P. J. Appl. Environ. Microbiol. 1998, 64, 1006.
44. (b) Schupp, J. M.; Travis, S. E.; Price, L. B.; Shand, R. F.; Keim, P. Biotechniques 1995, 19, 18.
45. Pitt, W. G.; McBride, M. O.; Lunceford, J. K.; Roper, R. J.; Sagers, R. D. Antimicrob. Agent Chemother. 1994, 38, 2577.